Robin D. Campbell
Président chez Aptitude Medical Systems, Inc.
Profil
Robin D.
Campbell is currently the Chairman of Aptitude Medical Systems, Inc. and a Director at Acelot, Inc. He previously served as the President & Chief Executive Officer of Naryx Pharma, Inc. from 2004 to 2008, and as the VP-US Oncology Business Unit & General Manager at Amgen, Inc. from 1989 to 2002.
He was also the President of Kirin-Amgen, Inc. from 1997 to 2000.
Campbell has held various other positions in the pharmaceutical industry, including Director at SEQUUS Pharmaceuticals, Inc., Principal at Ciba-Geigy Corp., and Independent Director at Pfenex, Inc. from 2014 to 2020.
Campbell holds a doctorate from Wake Forest School of Medicine and an undergraduate degree from The University of North Carolina at Charlotte.
Postes actifs de Robin D. Campbell
| Sociétés | Poste | Début |
|---|---|---|
Aptitude Medical Systems, Inc.
 Aptitude Medical Systems, Inc. Miscellaneous Commercial ServicesCommercial Services Aptitude Medical Systems, Inc. provides biotechnical research services. The company was founded by Jinpeng Wang, Qiang Gong and Scott Ferguson in 2011 and is headquartered in Santa Barbara, CA. | Président | 01/12/2011 |
| Acelot, Inc. | Directeur/Membre du Conseil | - |
Anciens postes connus de Robin D. Campbell
| Sociétés | Poste | Fin |
|---|---|---|
| PFENEX INC. | Directeur/Membre du Conseil | 01/10/2020 |
| SYMBIO PHARMACEUTICALS LIMITED | Directeur/Membre du Conseil | 01/03/2019 |
Naryx Pharma, Inc.
 Naryx Pharma, Inc. Pharmaceuticals: MajorHealth Technology Naryx Pharma, Inc. developd products for the treatment of chronic sinusitis. Its products were focused on inhaled, nebulizer, intranasal drug formulations. Its products include Sybryx, which is used for the treatment of chronic sinusitis. The company focused on development of inhaled, nebulized, and intranasal drug formulations. The company was founded in 1999 and was headquartered in Carpinteria, CA. | Directeur Général | 01/01/2008 |
| AMGEN INC. | Corporate Officer/Principal | 01/01/2002 |
Kirin-Amgen, Inc.
 Kirin-Amgen, Inc. Pharmaceuticals: MajorHealth Technology Part of Amgen, Inc., Kirin-Amgen, Inc. is a pharmaceutical company that manufactures drugs and provides licensing. The company is based in Thousand Oaks, CA. Kirin-Amgen was acquired by Amgen, Inc. from Kirin Holdings Co., Ltd. on January 29, 2018 for $810 million. | President | 01/01/2000 |
Formation de Robin D. Campbell
| Wake Forest School of Medicine | Doctorate Degree |
| The University of North Carolina at Charlotte | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| AMGEN INC. | Health Technology |
| SYMBIO PHARMACEUTICALS LIMITED | Health Technology |
| Entreprise privées | 7 |
|---|---|
| Ciba-Geigy Corp. | Health Technology |
SEQUUS Pharmaceuticals, Inc.
 SEQUUS Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology SEQUUS Pharmaceuticals, Inc. is based in Menlo Park, CA. Part of Johnson & Johnson, SEQUUS Pharmaceuticals, Inc. is a company that markets lipid-based biopharmaceutical products mainly to treat cancer and infectious diseases. SEQUUS Pharmaceuticals was acquired by ALZA Corp., part of Johnson & Johnson from June 22, 2001 on March 16, 1999 for $658.03 million. | Health Technology |
Naryx Pharma, Inc.
Naryx Pharma, Inc. Pharmaceuticals: MajorHealth Technology Naryx Pharma, Inc. developd products for the treatment of chronic sinusitis. Its products were focused on inhaled, nebulizer, intranasal drug formulations. Its products include Sybryx, which is used for the treatment of chronic sinusitis. The company focused on development of inhaled, nebulized, and intranasal drug formulations. The company was founded in 1999 and was headquartered in Carpinteria, CA. | Health Technology |
Kirin-Amgen, Inc.
Kirin-Amgen, Inc. Pharmaceuticals: MajorHealth Technology Part of Amgen, Inc., Kirin-Amgen, Inc. is a pharmaceutical company that manufactures drugs and provides licensing. The company is based in Thousand Oaks, CA. Kirin-Amgen was acquired by Amgen, Inc. from Kirin Holdings Co., Ltd. on January 29, 2018 for $810 million. | Health Technology |
Pelican Inc
 Pelican Inc BiotechnologyHealth Technology Pfenex, Inc. is a development and licensing Biotechnology Company, which focuses on leveraging its Pfenex Expression Technology platform for developing and improving protein therapies. Its products include PF708, PF743, PF745, CRM197, PF810, PF753 and PFXX. The company was founded on November 19, 2009 and is headquartered in San Diego, CA. | Health Technology |
| Acelot, Inc. | |
Aptitude Medical Systems, Inc.
Aptitude Medical Systems, Inc. Miscellaneous Commercial ServicesCommercial Services Aptitude Medical Systems, Inc. provides biotechnical research services. The company was founded by Jinpeng Wang, Qiang Gong and Scott Ferguson in 2011 and is headquartered in Santa Barbara, CA. | Commercial Services |